MedPath
HSA Approval

BECLO-ASMA CFC FREE INHALLER 250mcg

SIN13671P

BECLO-ASMA CFC FREE INHALLER 250mcg

BECLO-ASMA CFC FREE INHALLER 250mcg

July 9, 2009

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

AEROSOL, METERED

RESPIRATORY (INHALATION)

Medical Information

R03BA01

beclometasone

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Laboratorio Aldo-Union S.L.

Active Ingredients

beclometasone dipropionate anhydrous

250mcg/dose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BECLO-ASMA CFC FREE INHALLER 250mcg - HSA Approval | MedPath